LENZ THERAPEUTICS, INC. (LENZ)

5.11 +6.24% (+0.30)

Over 6M: -62.6%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

5 10
Mar Apr May Jun Jul Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '23 — Operating Cash Flow: -13.1M Q3 '23 — Free Cash Flow: -13.1M Q3 '23 — Net Income: -18.9M Q4 '23 — Operating Cash Flow: -21M Q4 '23 — Free Cash Flow: -21M Q4 '23 — Net Income: -23.7M Q1 '24 — Operating Cash Flow: -23.9M Q1 '24 — Free Cash Flow: -23.9M Q1 '24 — Net Income: -16.6M Q2 '24 — Revenue: 0 Q2 '24 — Operating Cash Flow: -15.8M Q2 '24 — Free Cash Flow: -15.9M Q2 '24 — Net Income: -10.3M Q3 '24 — Revenue: 0 Q3 '24 — Operating Cash Flow: -10.6M Q3 '24 — Free Cash Flow: -10.8M Q3 '24 — Net Income: -10.2M Q4 '24 — Operating Cash Flow: -9.1M Q4 '24 — Free Cash Flow: -9.2M Q4 '24 — Net Income: -12.7M Q1 '25 — Revenue: 0 Q1 '25 — Operating Cash Flow: -16M Q1 '25 — Free Cash Flow: -16.2M Q1 '25 — Net Income: -14.6M Q2 '25 — Revenue: 5M Q2 '25 — Operating Cash Flow: -11.5M Q2 '25 — Free Cash Flow: -11.7M Q2 '25 — Net Income: -14.9M Q3 '25 — Revenue: 12.5M Q3 '25 — Operating Cash Flow: -8.6M Q3 '25 — Free Cash Flow: -9M Q3 '25 — Net Income: -16.7M Q4 '25 — Revenue: 1.6M Q4 '25 — Operating Cash Flow: -33M Q4 '25 — Free Cash Flow: -33.1M Q4 '25 — Net Income: -35.9M Q1 '26 — Revenue: 1.9M Q1 '26 — Operating Cash Flow: -33.6M Q1 '26 — Free Cash Flow: -33.6M Q1 '26 — Net Income: -41.5M Q2 '26 — Revenue: 5.5M Q2 '26 — Operating Cash Flow: -38.7M Q2 '26 — Free Cash Flow: -38.7M Q2 '26 — Net Income: -31.9M -30M -15M 0 15M
Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2025-12-31, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 83.5%
OE margin -682.9%
Oper. margin -710.7%
ROIC -564.3%
Accruals -5.1%
Gross margin 97.8%
Asset turnover 0.081×
EBITDA margin -708.3%
FCF margin -599.4%
OCF margin -596.8%
Profit margin -660.1%
ROA -53.3%
ROCE -61.8%
ROE -57.5%
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.9
RPO / sales 0.041×
RPO growth —
Segment HHI —

1 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

7.0
Current ratio 14.2×
ND/EBITDA —
Cash runway 1.8 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 13.3×
F-score 2.6 pts
Cash / Debt —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0
Shares change +35.4%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —
Sales Q/Q —
Sales/sh Y/Y —

1 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.